You must have an order with a minimum of $100.00 to place your order, your current order total is $94.50.
- Total cost of products in cart must be $150.00 or more
Wegovy 2.4mg Pen (9.6mg TOTAL) [Semaglutide Injection] (3.2mg/mL) – 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE
$400.00
WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION
Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.
This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.
The Details:
-
Dosage: 2.4mg semaglutide per dose
-
Form: Prefilled injection pen
-
Quantity: Single-use pen, ready for controlled application
-
Packaging: Sterile, tamper-evident pen in sealed packaging
-
Source: Canadian pharmaceutical grade, third-party tested for purity and consistency
Key Features of Wegovy 2.4mg:
-
Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.
-
GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.
-
Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.
-
Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.
-
Pharmaceutical Authenticity: Canadian-produced and independently verified.
For more products, visit: https://www.canadasteroiddepot.is/
WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION
Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.
This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.
The Details:
-
Dosage: 2.4mg semaglutide per dose
-
Form: Prefilled injection pen
-
Quantity: Single-use pen, ready for controlled application
-
Packaging: Sterile, tamper-evident pen in sealed packaging
-
Source: Canadian pharmaceutical grade, third-party tested for purity and consistency
Key Features of Wegovy 2.4mg:
-
Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.
-
GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.
-
Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.
-
Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.
-
Pharmaceutical Authenticity: Canadian-produced and independently verified.
For more products, visit: https://www.canadasteroiddepot.is/